Enrollment is now complete in two Phase 3 clinical trials testing vidofludimus calcium in adults with relapsing forms of ...

Dr. Susan Payrovi and Dr. Mirla Avila have an in-depth discussion around treating MS, and considerations when selecting an MS treatment.

Historically, optic nerve involvement has been excluded from MS diagnostic criteria, but its inclusion in the new iteration ...

A growing body of evidence is shifting expert opinion toward supporting MS treatment during pregnancy, emphasizing ...

We’ve probably all heard about the immune-mediated disease Multiple Sclerosis (MS ... The disease causes damage to the myelin, which is the fatty substance that covers the nerve fibers and keeps them ...

Multiple sclerosis is an incurable condition that can occur at any point in life However it is most common in young adults – ...

The molecular mechanisms underlying myelin sheath destruction in multiple sclerosis lesions remain ... myelin protein mediate target membrane damage in central nervous system demyelinating disease.

Two radiologists blinded to clinical data independently evaluated MRIs for the enhancement of the optic nerve sheath (ONS ... demonstrating the potential value of MRI in multiple orbital pathologies ...

Multiple sclerosis causes numbness and tingling in the face, arms, legs, and other parts of the body, as it affects the nerves that send signals between the brain and body.

Patients on fenebrutinib had low relapse rates with data showing no active brain lesions or disability progression after nearly two years of treatment Phase III studies for fenebrutinib in relapsing ...

The electromyogram findings revealed multiple peripheral nerve damage ... in these MRI results such as Dawson fingers sign. In terms of disease progression, the patient did not meet any of the four ...

Multiple sclerosis (MS) is a nervous system disease that affects your brain and spinal cord. It damages the myelin sheath, the material that surrounds and protects your nerve cells. This damage slows ...